Harmonic Torsional Diffusion for Protein-Ligand Flexible Docking
Read the original on arXiv Machine Learning →The Flow has not summarised this story yet — read it at arXiv Machine Learning.
The Flow has not summarised this story yet — read it at arXiv Machine Learning.
arXiv:2506. 14488v2 Announce Type: replace-cross Abstract: Structure-based drug design (SBDD) models are central to modern pharmaceutical research, enabling the rational exploration of protein-ligand interactions at atomic resolution.
The paper introduces a curriculum learning strategy for generative flexible docking, a task that predicts protein‑ligand complex configurations from an apo protein structure and a ligand SMILES string. By gradually incorporating examples with large conformational changes during training, the authors enhance an existing generative model, achieving a 46.52% top‑1 success rate on the PDBBind ESMFold apo benchmark and outperforming prior baselines. The approach leverages diffusion and flow‑based generative models to model the posterior distribution over ligand poses and protein conformations conditioned on the apo input.
Matcha is a new molecular docking method that refines ligand poses through three flow-matching stages—translation, rotation, and torsion—before applying GNINA for minimization, filtering, and ranking. It achieves high physical plausibility and is approximately 28 times faster than current large-scale co‑folding models, outperforming existing benchmarks. The authors provide code, benchmarking artifacts, and model checkpoints on GitHub and Zenodo.
MLIPDiff is an inference‑time guidance technique that enhances pretrained denoising diffusion models for ligand generation by incorporating physics‑informed guidance from a machine‑learned interatomic potential (UMA). It combines four weighted energy terms—protein‑ligand interaction, ligand strain, steric clash, and pocket anchoring—to eliminate protein‑ligand collisions while preserving local geometry, without requiring model retraining. On the CrossDocked2020 benchmark, MLIPDiff produces clash‑free, physically plausible ligand poses and achieves superior binding‑affinity metrics compared to both the base diffusion model and NucleusDiff.
arXiv:2606. 05198v1 Announce Type: cross Abstract: Nucleic acids are increasingly recognized as therapeutic targets beyond conventional protein-centered drug discovery, yet accurate and efficient docking of small molecules to nucleic acid structures remains challenging.
arXiv:2606. 14159v1 Announce Type: new Abstract: Protein-ligand binding affinity (PLA) prediction is critical in drug discovery.